Endo Trap HD 

To Order Contact us: stephen@expresspharmapulse.com

ENDO AGAR
E05-110-10kg 10 kg
EUR 2857.2

ENDO AGAR
E05-110-2Kg 2 Kg
EUR 668.4

ENDO AGAR
E05-110-500g 500 g
EUR 225.6

TRAP-6
A8675-5 5 mg
EUR 207.6
Description: Peptide fragment (residues 42-47) of protease-activated receptor 1 (PAR1) that acts as a PAR1 agonist. Stimulates platelet aggregation (EC50 = 0.8 ?M), promotes intracellular Ca2+ mobilization and induces rapid phosphodiesterase 3A (PDE3A) phosphorylation

TRAP Antibody
6911-002mg 0.02 mg
EUR 206.18
Description: TRAP Antibody: TRAP, also known as uteroferrin, is an iron containing, glycosylated, acid phosphatase. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. Along with the related protein ACP2, TRAP mediates the removal of mannose 6-phosphate residues from proteins targeted to lysosomes. TRAP is present in brain at low levels, but is expressed at a much higher level in liver.

TRAP Antibody
6911-01mg 0.1 mg
EUR 523.7
Description: TRAP Antibody: TRAP, also known as uteroferrin, is an iron containing, glycosylated, acid phosphatase. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. Along with the related protein ACP2, TRAP mediates the removal of mannose 6-phosphate residues from proteins targeted to lysosomes. TRAP is present in brain at low levels, but is expressed at a much higher level in liver.

TRAP Peptide
6911P 0.05 mg
EUR 197.7
Description: (CT) TRAP peptide

TRAP-14
5-02017 4 x 5mg Ask for price

TRAP antibody
70R-12535 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal TRAP antibody

TRAP antibody
22406-100ul 100ul
EUR 468

TRAP Antibody
25505-100ul 100ul
EUR 468

TRAP -6
ABP-TRA-1 5,0mg vial
EUR 204

Trap 101
B7084-10 10 mg
EUR 447.6

Trap 101
B7084-50 50 mg
EUR 1635.6

TRAP-6
HY-P0078 10mM/1mL
EUR 386.4

TRAP-6
H-7764.0500 0.5mg
EUR 57.6
Description: Sum Formula: C34H56N10O9; CAS# [141136-83-6] net

TRAP-6
H-7764.1000 1.0mg
EUR 72
Description: Sum Formula: C34H56N10O9; CAS# [141136-83-6] net

TRAP-14
H-8105.0001 1.0mg
EUR 181.2
Description: Sum Formula: C81H118N20O23; CAS# [137339-65-2] net

TRAP-14
H-8105.0005 5.0mg
EUR 618
Description: Sum Formula: C81H118N20O23; CAS# [137339-65-2] net

TRAP-6
H-8365.0005 5.0mg
EUR 327.6
Description: Sum Formula: C34H56N10O9; CAS# [141136-83-6] net

TRAP-6
H-8365.0025 25.0mg
EUR 1197.6
Description: Sum Formula: C34H56N10O9; CAS# [141136-83-6] net

TRAP-7
H-2234.0005 5.0mg
EUR 646.8
Description: Sum Formula: C39H63N11O10; CAS# [145229-76-1] net

TRAP-7
H-2234.0025 25.0mg
EUR 2473.2
Description: Sum Formula: C39H63N11O10; CAS# [145229-76-1] net

TRAP-5
H-1408.0005 5.0mg
EUR 691.2
Description: Sum Formula: C30H50N8O7; CAS# [141685-53-2] net

TRAP-5
H-1408.0025 25.0mg
EUR 2648.4
Description: Sum Formula: C30H50N8O7; CAS# [141685-53-2] net

Rat(TRAP)
QY-E11743 96T
EUR 448.8

pTALETF_v2 HD Plasmid
PVT6207 2 ug
EUR 319.2

pTALEN_v2 HD Plasmid
PVT6211 2 ug
EUR 614.4

Endo G Antibody
DF8541 200ul
EUR 420

Endo G Antibody
45339-100ul 100ul
EUR 302.4

Endo G Antibody
45339-50ul 50ul
EUR 224.4

Endo G Antibody
49763-100ul 100ul
EUR 399.6

Endo G Antibody
49763-50ul 50ul
EUR 286.8

Endo G Antibody
ABD8541 100 ug
EUR 525.6

IWR-1-endo
B2306-10 10 mg
EUR 157.2
Description: IWR-1-endo is a small molecule inhibitor of Wnt Response with IC50 value of 180nM [1].IWR-1-endo is a small molecule antagonists of the Wnt/?-catenin pathway screened out from a diverse synthetic chemical library.

IWR-1-endo
B2306-25 25 mg
EUR 268.8
Description: IWR-1-endo is a small molecule inhibitor of Wnt Response with IC50 value of 180nM [1].IWR-1-endo is a small molecule antagonists of the Wnt/?-catenin pathway screened out from a diverse synthetic chemical library.

IWR-1-endo
B2306-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: IWR-1-endo is a small molecule inhibitor of Wnt Response with IC50 value of 180nM [1].IWR-1-endo is a small molecule antagonists of the Wnt/?-catenin pathway screened out from a diverse synthetic chemical library.

ENDO-Growth Media
MED001 500 ml
EUR 434.4

ENDO Basal Media
MED002 500 ml
EUR 248.4

ENDO-Growth Supplements
EGS001 25 ml
EUR 292.8

anti-Endo G
YF-PA11561 50 ul
EUR 435.6
Description: Mouse polyclonal to Endo G

anti-Endo G
YF-PA11562 50 ug
EUR 435.6
Description: Mouse polyclonal to Endo G

TRAP Conjugated Antibody
C44711 100ul
EUR 476.4

TRAP Conjugated Antibody
C36331 100ul
EUR 476.4

TRAP Conjugated Antibody
C38129 100ul
EUR 476.4

[Cit5]-TRAP-5
5-00062 4 x 5mg Ask for price

[Tyr1]-TRAP-7
5-00339 4 x 5mg Ask for price

Scrambled TRAP Fragment
5-01910 4 x 5mg Ask for price

TRAP-14 amide
5-02018 4 x 1mg Ask for price

TRAP-5 amide
5-02019 4 x 5mg Ask for price

TRAP-14 Peptide
20-abx266463
  • EUR 661.20
  • EUR 1111.20
  • EUR 477.60
  • 10 mg
  • 25 mg
  • 5 mg

Polyclonal TRAP Antibody
APR10538G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TRAP . This antibody is tested and proven to work in the following applications:

TRAP-14 amide
H-6032.0001 1.0mg
EUR 254.4
Description: Sum Formula: C81H119N21O22; CAS# [141923-36-6] net

TRAP-14 amide
H-6032.0005 5.0mg
EUR 907.2
Description: Sum Formula: C81H119N21O22; CAS# [141923-36-6] net

TRAP-6 amide
H-2936.0005 5.0mg
EUR 138
Description: Sum Formula: C34H57N11O8; CAS# [141923-40-2] net

TRAP-6 amide
H-2936.0025 25.0mg
EUR 441.6
Description: Sum Formula: C34H57N11O8; CAS# [141923-40-2] net

TRAP-5 amide
H-2938.0025 25.0mg
EUR 646.8
Description: Sum Formula: C30H51N9O6; CAS# [141923-41-3] net

TRAP-5 amide
H-2938.0100 100.0mg
EUR 1864.8
Description: Sum Formula: C30H51N9O6; CAS# [141923-41-3] net

(Tyr1)-TRAP-7
H-1674.0001 1.0mg
EUR 151.2
Description: Sum Formula: C45H67N11O10; CAS# [149440-16-4] net

(Tyr1)-TRAP-7
H-1674.0005 5.0mg
EUR 501.6
Description: Sum Formula: C45H67N11O10; CAS# [149440-16-4] net

CD40 Ligand/TRAP
PR29002 50 ug
EUR 589.2

Anti-TRAP antibody
STJ190098 200 µl
EUR 236.4
Description: Unconjugated Mouse monoclonal to TRAP (2H2)

anti-TRAP alpha
YF-PA14790 50 ul
EUR 435.6
Description: Mouse polyclonal to TRAP alpha

anti-TRAP alpha
YF-PA14791 50 ug
EUR 435.6
Description: Mouse polyclonal to TRAP alpha

Gst Spin Trap
28952359 PK50
EUR 448.02

TRAP Antibody (CD40L)
F49677-0.08ML 0.08 ml
EUR 165

TRAP Antibody (CD40L)
F49677-0.4ML 0.4 ml
EUR 379

Mouse HD ELISA Kit
EMH0241 96Tests
EUR 625.2

Human HD ELISA Kit
EHH0241 96Tests
EUR 625.2

Rat HD ELISA Kit
ERH0241 96Tests
EUR 625.2

Rabbit HD ELISA Kit
ERTH0241 96Tests
EUR 625.2

Porcine HD ELISA Kit
EPH0241 96Tests
EUR 625.2

Goat HD ELISA Kit
EGTH0241 96Tests
EUR 625.2

Bovine HD ELISA Kit
EBH0241 96Tests
EUR 625.2

Canine HD ELISA Kit
ECH0241 96Tests
EUR 625.2

Anserini HD ELISA Kit
EAH0241 96Tests
EUR 625.2

Foam bung 38x50mm hd
FOB010 PK100
EUR 33.63

Tubes 50ml Conical HD
X13758 PK12
EUR 197.22

Endo G Rabbit mAb
A8801 20 μL
EUR 18

Endo G Blocking Peptide
DF8541-BP 1mg
EUR 234

Endo G Conjugated Antibody
C49763 100ul
EUR 476.4

Endo G Conjugated Antibody
C45339 100ul
EUR 476.4

M-ENDO AGAR, LES
M13-124-10kg 10 kg
EUR 3082.8

M-ENDO AGAR, LES
M13-124-2Kg 2 Kg
EUR 717.6

M-ENDO AGAR, LES
M13-124-500g 500 g
EUR 238.8

ENDO-Growth Media Kit
EGK001 500 ml
EUR 434.4

Endo-38a-Pro-Exenatide
H-7492.0100 0.1mg
EUR 163.2
Description: Sum Formula: C189H289N51O61S; CAS# [1678416-95-9] net

Endo-38a-Pro-Exenatide
H-7492.0500 0.5mg
EUR 542.4
Description: Sum Formula: C189H289N51O61S; CAS# [1678416-95-9] net

(1R)-Endo-(+)-Fenchyl Alc
S-7604 EACH
EUR 69.54

Falcon Hd Translucent 3um Hd Pet Membrane For 12 Well Plate
353292 PK48
EUR 387.6

Falcon Hd Translucent 3um Hd Pet Membrane For 24 Well Plate
353492 PK48
EUR 387.6

Falcon Hd Translucent 0.4um Hd Pet Membrane For 24 Well Plate
353493 PK48
EUR 449.16

Falcon Hd Translucent 0.45um Hd Pet Membrane For 12 Well Plate
353494 PK48
EUR 387.6

Falcon Hd Translucent 0.45um Hd Pet Membrane For 24 Well Plate
353495 PK48
EUR 384.18

Sheep TRAP ELISA Kit
EST0544 96Tests
EUR 625.2

Human TRAP ELISA Kit
EHT0544 96Tests
EUR 625.2

Porcine TRAP ELISA Kit
EPT0544 96Tests
EUR 625.2

Monkey TRAP ELISA Kit
EMKT0544 96Tests
EUR 625.2

Mouse TRAP ELISA Kit
EMT0544 96Tests
EUR 625.2

Rat TRAP ELISA Kit
ERT0544 96Tests
EUR 625.2

[Phe1, Ser2]-TRAP-6
5-00263 4 x 5mg Ask for price

TRAP-6 (2-6)
5-02020 4 x 5mg Ask for price

TRAP-5 amide Peptide
20-abx265852
  • EUR 427.20
  • EUR 644.40
  • EUR 343.20
  • 10 mg
  • 25 mg
  • 5 mg

Scrambled TRAP Fragment Peptide
20-abx265858
  • EUR 427.20
  • EUR 644.40
  • EUR 343.20
  • 10 mg
  • 25 mg
  • 5 mg

[Tyr1]-TRAP-7 Peptide
20-abx265889
  • EUR 427.20
  • EUR 644.40
  • EUR 343.20
  • 10 mg
  • 25 mg
  • 5 mg

[Cit5]-TRAP-5 Peptide
20-abx265945
  • EUR 460.80
  • EUR 710.40
  • EUR 360.00
  • 10 mg
  • 25 mg
  • 5 mg

Anti-TRAP Monoclonal Antibody
M03277-1 100ug
EUR 476.4
Description: Rabbit Monoclonal TRAP Antibody. Validated in IP, IF, IHC, ICC, WB and tested in Human, Mouse, Rat.

Goat TRAP ELISA Kit
EGTT0544 96Tests
EUR 625.2

Bovine TRAP ELISA Kit
EBT0544 96Tests
EUR 625.2

Mouse TRAP ELISA Kit
ELI-03023m 96 Tests
EUR 1038

(Phe1,Ser2)-TRAP-6
H-5996.0005 5.0mg
EUR 356.4
Description: Sum Formula: C34H56N10O9; CAS# [374898-11-0] net

(Phe1,Ser2)-TRAP-6
H-5996.0025 25.0mg
EUR 1311.6
Description: Sum Formula: C34H56N10O9; CAS# [374898-11-0] net

TRAP-6 (2-6)
H-8325.0005 5.0mg
EUR 327.6
Description: Sum Formula: C31H51N9O7; CAS# [141136-84-7] net

TRAP-6 (2-6)
H-8325.0025 25.0mg
EUR 1197.6
Description: Sum Formula: C31H51N9O7; CAS# [141136-84-7] net

(DL-Isoser1)-TRAP-6
H-1944.0001 1.0mg
EUR 327.6
Description: Sum Formula: C34H56N10O9; CAS# [150242-29-8] net

(DL-Isoser1)-TRAP-6
H-1944.0005 5.0mg
EUR 1197.6
Description: Sum Formula: C34H56N10O9; CAS# [150242-29-8] net

Chicken TRAP ELISA Kit
ECKT0544 96Tests
EUR 625.2

Canine TRAP ELISA Kit
ECT0544 96Tests
EUR 625.2

CD40 Ligand/TRAP (Soluble)
PR27033 50 ug
EUR 608.4

Anti-TRAP alpha (1C11)
YF-MA15622 100 ug
EUR 435.6
Description: Mouse monoclonal to TRAP alpha

Anti-TRAP alpha (1A12)
YF-MA10883 100 ug
EUR 435.6
Description: Mouse monoclonal to TRAP alpha

VENT FILTER / C02 TRAP
ZFRE012FC EACH
EUR 440.04

TRAP-1 Antibody / HSP75
R32204 100 ug
EUR 419

CD40L Antibody / TRAP / CD154
RQ4070 100 ug
EUR 419

Cd40l Antibody / Trap / Cd154
RQ4071 100 ug
EUR 419

CD40L Antibody / TRAP / CD154
RQ4900 100ug
EUR 419

TRAcP Antibody / TRAP / ACP5
RQ5412 100 ul
EUR 419

CD40L Antibody / TRAP / CD154
V8248-100UG 100 ug
EUR 499
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD40L Antibody / TRAP / CD154
V8248-20UG 20 ug
EUR 219
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD40L Antibody / TRAP / CD154
V8248SAF-100UG 100 ug
EUR 499
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD154 Antibody / CD40L / TRAP
RQ6411 100 ug
EUR 419
Description: CD154 (CD40 ligand) is a type II membrane protein of 261 amino acids on activated T cells that induces B cell proliferation and immunoglobulin secretion. It has homology with tumour necrosis factor-alpha and -beta, and has important functions in B-cell activation and differentiation. Human CD154 with 5 exons, is mapped to the proximal region of the mouse X chromosome on Xq26.3-27.1, and can be detected on T cells but is absent from B cells and monocytes. Since it is expressed on platelets and released from them on activation, its predictive value as a marker for clinical outcome and the therapeutic effect of inhibition of glycoprotein IIb /IIIa receptor in patients with acute coronary syndromes was investigated. The soluble for of the protein may be involved in the process of restenosis and that it exerts its effect by triggering a complex group of inflammatory reactions on endothelial and mononuclear cells. CD154 plays a central role in the pathophysiology of acute coronary syndromes, and has a role in the pathogenesis of coronary artery lesions.

Cd40l Antibody / Trap / Cd154
RQ6604 100ug
EUR 419
Description: CD40 ligand (CD40L) is a type II membrane protein of 261 amino acids on activated T cells that induces B cell proliferation and immunoglobulin secretion. It has homology with tumor necrosis factor-alpha and -beta, and has important functions in B-cell activation and differentiation. Human CD40L with 5 exons, is mapped to the proximal region of the mouse X chromosome on Xq26.3-27.1, and can be detected on T cells but is absent from B cells and monocytes. Since CD40L is expressed on platelets and released from them on activation, its predictive value as a marker for clinical outcome and the therapeutic effect of inhibition of glycoprotein IIb /IIIa receptor in patients with acute coronary syndromes was investigated. The soluble CD40L may be involved in the process of restenosis and that it exerts its effect by triggering a complex group of inflammatory reactions on endothelial and mononuclear cells. CD40L plays a central role in the pathophysiology of acute coronary syndromes, and has a role in the pathogenesis of coronary artery lesions.

TRAP-1 Antibody / HSP75
RQ6811 100ug
EUR 419
Description: Heat shock protein 75 kDa, mitochondrial is a protein that in humans is encoded by the TRAP1 gene. It is mapped to 16p13.3. This gene encodes a mitochondrial chaperone protein that is member of the heat shock protein 90 (HSP90) family. The encoded protein has ATPase activity and interacts with tumor necrosis factor type I. And this protein may function in regulating cellular stress responses. In addition, it was found that TRAP1 interacted with the N-terminal half of TNFR1. Also, TRAP1 interacted with the C-terminal ends of the proteins encoded by both multiple exostoses-causing genes, EXT1 and EXT2, but not with EXTL1 or EXTL3.

ACP5/TRAP, human recombinant
P1055-10 each
EUR 196.8

ACP5/TRAP, human recombinant
P1055-50 each
EUR 705.6

TRAcP Antibody / TRAP / ACP5
F47709-0.08ML 0.08 ml
EUR 165

TRAcP Antibody / TRAP / ACP5
F47709-0.4ML 0.4 ml
EUR 379

TRAP-1 Antibody (HSP75)
F43545-0.08ML 0.08 ml
EUR 165

TRAP-1 Antibody (HSP75)
F43545-0.4ML 0.4 ml
EUR 379

TRAcP Antibody / TRAP / ACP5
V7136-100UG 100 ug
EUR 499
Description: Tartrate-Resistant Acid Phosphatase is involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias. [UniProt]

TRAcP Antibody / TRAP / ACP5
V7136-20UG 20 ug
EUR 219
Description: Tartrate-Resistant Acid Phosphatase is involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias. [UniProt]

TRAcP Antibody / TRAP / ACP5
V7136SAF-100UG 100 ug
EUR 499
Description: Tartrate-Resistant Acid Phosphatase is involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias. [UniProt]

CD40L Antibody / TRAP / CD154
V7385-100UG 100 ug
EUR 499
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD40L Antibody / TRAP / CD154
V7385-20UG 20 ug
EUR 219
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD40L Antibody / TRAP / CD154
V7385IHC-7ML 7 ml
EUR 499
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD40L Antibody / TRAP / CD154
V7385SAF-100UG 100 ug
EUR 499
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

TRAcP Antibody / TRAP / ACP5
V2794-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This mAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher's Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V2794-20UG 20 ug
EUR 219
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This mAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher's Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V2794SAF-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This mAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher's Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V2795-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This mAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V2795-20UG 20 ug
EUR 219
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This mAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V2795SAF-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This mAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3534-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3534-20UG 20 ug
EUR 219
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3534IHC-7ML 7 ml
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3534SAF-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3535-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3535-20UG 20 ug
EUR 219
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3535IHC-7ML 7 ml
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

TRAcP Antibody / TRAP / ACP5
V3535SAF-100UG 100 ug
EUR 499
Description: It recognizes a protein of 35kDa, which is identified as tartrate-resistant acid phosphatase (TRAcP). It exists as two isoforms (5a and 5b). This MAb reacts with both the isoforms. Serum TRAcP 5a is secreted by macrophages and dendritic cells and increased in many patients of rheumatoid arthritis. Serum TRAcP 5b is produced from osteoclasts and elevated during bone resorption. TRAcP is an iron containing glycoprotein, which catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is the most basic of the acid phosphatases and is the only form not inhibited by L(+)-tartrate. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. Expression of TRAcP is increased in certain pathological conditions such as Leukemic Reticuloendotheliosis (Hairy Cell Leukemia), Gaucher’s Disease, HIV-induced Encephalopathy, Osteoclastoma and in osteoporosis and metabolic bone diseases. Anti-TRAcP antibody labels the cells of Hairy Cell Leukemia (HCL) with a high degree of sensitivity and specificity. Other cells stained with this antibody are tissue macrophages and osteoclasts.

CD40L Antibody / TRAP / CD154
V8828-100UG 100ug
EUR 499
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

CD40L Antibody / TRAP / CD154
V8828-20UG 20ug
EUR 219
Description: CD40LG expression is mainly confined to the CD4-positive-T-cell subset. Its expression is induced shortly after T-cell activation and represents an early activation marker of T lymphocytes. CD40 is constitutively expressed mainly on B cells, macrophages, and dendritic cells. The CD40-CD40L pathway has been shown to play multiple functional roles in the healthy immune system. It enhances the antigen-specific T-cell response through the activation of dendritic cells and the induction of interleukin-12 production. For example, engagement of CD40 on endothelial cells by activated T cells expressing CD40L leads to upregulation of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin. Activation of APC by CD40-CD40L interaction induces the production of inflammatory cytokines, chemokines, NO, and metalloproteinases. Interaction of CD4-positiveCD40LG-positiveT cells with CD40 on B cells leads to B-cell differentiation, proliferation, immunoglobulin (Ig) isotype switching, and formation of memory B cells.

Endo Trap HD